Terms: = Kidney tumors AND ATR, Q13535, 545, ENSG00000175054, MEC1, SCKL, SCKL1, FRP1 AND Treatment
29 results:
1. Robotic-assisted laparoscopic surgery for the treatment of Wilms' tumor in children: single-center experience and medium-term outcomes.
Li P; Tao Y; Zhao Y; Lyu X; Zhou X; Zhuo R; Ma L; Tao T; Zhou H
J Robot Surg; 2024 Jan; 18(1):3. PubMed ID: 38175361
[TBL] [Abstract] [Full Text] [Related]
2. Analysis of Quinolinequinone Analogs with Promising Cytotoxic Activity against Breast Cancer.
Yilmaz Goler AM; Tarbin Jannuzzi A; Biswas A; Mondal S; Basavanakatti VN; Jayaprakash Venkatesan R; Yıldırım H; Yıldız M; Çelik Onar H; Bayrak N; Jayaprakash V; TuYuN AF
Chem Biodivers; 2023 Sep; 20(9):e202300848. PubMed ID: 37590495
[TBL] [Abstract] [Full Text] [Related]
3. SETD2 Loss and atr Inhibition Synergize to Promote cGAS Signaling and Immunotherapy Response in Renal Cell Carcinoma.
Liu XD; Zhang YT; McGrail DJ; Zhang X; Lam T; Hoang A; Hasanov E; Manyam G; Peterson CB; Zhu H; Kumar SV; Akbani R; Pilie PG; Tannir NM; Peng G; Jonasch E
Clin Cancer Res; 2023 Oct; 29(19):4002-4015. PubMed ID: 37527013
[TBL] [Abstract] [Full Text] [Related]
4. Relationships Between Urinary and Nonurinary Symptoms in treatment-Seeking Women in LURN.
Smith AR; Mansfield SA; Bradley CS; Kenton KS; Helmuth ME; Cameron AP; Kirkali Z; Bretschneider CE; Andreev V; Sarma A; Lane G; Collins SA; Cella D; Lai HH; Harte SE; Griffith JW;
Urogynecology (Phila); 2024 Feb; 30(2):123-131. PubMed ID: 37428882
[TBL] [Abstract] [Full Text] [Related]
5. atr represents a therapeutic vulnerability in clear cell renal cell carcinoma.
Seidel P; Rubarth A; Zodel K; Peighambari A; Neumann F; Federkiel Y; Huang H; Hoefflin R; Adlesic M; Witt C; Hoffmann DJ; Metzger P; Lindemann RK; Zenke FT; Schell C; Boerries M; von Elverfeldt D; Reichardt W; Follo M; Albers J; Frew IJ
JCI Insight; 2022 Dec; 7(24):. PubMed ID: 36413415
[TBL] [Abstract] [Full Text] [Related]
6. External Validation of a Novel Risk Model in Patients With Favorable Risk Renal Cell Carcinoma Defined by International Metastatic Renal Cell Carcinoma Database Consortium (IMDC): Results From the Turkish Oncology Group kidney Cancer Consortium (TKCC) Database.
Yekedüz E; Karakaya S; Ertürk İ; Tural D; Uçar G; Şentürk Öztaş N; Arıkan R; Hızal M; Küçükarda A; Sever ÖN; Arslan Ç; Can O; Kılıçkap S; Yazgan C; Karadurmuş N; Şendur MA; Çiçin İ; Demirci U; Özgüroğlu M; Öksüzoğlu B; Ürün Y
Clin Genitourin Cancer; 2023 Feb; 21(1):175-182. PubMed ID: 35970759
[TBL] [Abstract] [Full Text] [Related]
7. Prospective Multicenter Comparison of Open and Robotic Radical Prostatectomy: The PROST-QA/RP2 Consortium.
Chang P; Wagner AA; Regan MM; Smith JA; Saigal CS; Litwin MS; Hu JC; Cooperberg MR; Carroll PR; Klein EA; Kibel AS; Andriole GL; Han M; Partin AW; Wood DP; Crociani CM; Greenfield TK; Patil D; Hembroff LA; Davis K; Stork L; Spratt DE; Wei JT; Sanda MG;
J Urol; 2022 Jan; 207(1):127-136. PubMed ID: 34433304
[TBL] [Abstract] [Full Text] [Related]
8. COL5A2 as a potential clinical biomarker for gastric cancer and renal metastasis.
Ding YL; Sun SF; Zhao GL
Medicine (Baltimore); 2021 Feb; 100(7):e24561. PubMed ID: 33607786
[TBL] [Abstract] [Full Text] [Related]
9. Sorafenib as a second-line treatment in metastatic renal cell carcinoma in Mexico: a prospective cohort study.
Martín-Aguilar AE; Núñez-López H; Ramirez-Sandoval JC
BMC Cancer; 2021 Jan; 21(1):16. PubMed ID: 33402115
[TBL] [Abstract] [Full Text] [Related]
10. Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial.
Zhu AX; Kang YK; Yen CJ; Finn RS; Galle PR; Llovet JM; Assenat E; Brandi G; Pracht M; Lim HY; Rau KM; Motomura K; Ohno I; Merle P; Daniele B; Shin DB; Gerken G; Borg C; Hiriart JB; Okusaka T; Morimoto M; Hsu Y; Abada PB; Kudo M;
Lancet Oncol; 2019 Feb; 20(2):282-296. PubMed ID: 30665869
[TBL] [Abstract] [Full Text] [Related]
11. WEE1 inhibition targets cell cycle checkpoints for triple negative breast cancers to overcome cisplatin resistance.
Zheng H; Shao F; Martin S; Xu X; Deng CX
Sci Rep; 2017 Mar; 7():43517. PubMed ID: 28262781
[TBL] [Abstract] [Full Text] [Related]
12. Trends and Patterns of Disparities in Cancer Mortality Among US Counties, 1980-2014.
Mokdad AH; Dwyer-Lindgren L; Fitzmaurice C; Stubbs RW; Bertozzi-Villa A; Morozoff C; Charara R; Allen C; Naghavi M; Murray CJ
JAMA; 2017 Jan; 317(4):388-406. PubMed ID: 28118455
[TBL] [Abstract] [Full Text] [Related]
13. Effects of everolimus on tuberous sclerosis complex-associated renal angiomyolipoma: A preliminary report.
Tsai JD; Wei CC; Yang SH; Fan HC; Hsu CC; Tung MC; Tsai ML; Sheu JN
Nephrology (Carlton); 2017 Dec; 22(12):1017-1022. PubMed ID: 27565896
[TBL] [Abstract] [Full Text] [Related]
14. Patient-Level DNA Damage and Repair Pathway Profiles and Prognosis After Prostatectomy for High-Risk Prostate Cancer.
Evans JR; Zhao SG; Chang SL; Tomlins SA; Erho N; Sboner A; Schiewer MJ; Spratt DE; Kothari V; Klein EA; Den RB; Dicker AP; Karnes RJ; Yu X; Nguyen PL; Rubin MA; de Bono J; Knudsen KE; Davicioni E; Feng FY
JAMA Oncol; 2016 Apr; 2(4):471-80. PubMed ID: 26746117
[TBL] [Abstract] [Full Text] [Related]
15. Use of metformin and risk of kidney cancer in patients with type 2 diabetes.
Tseng CH
Eur J Cancer; 2016 Jan; 52():19-25. PubMed ID: 26630530
[TBL] [Abstract] [Full Text] [Related]
16. Copper-64-labeled anti-bcl-2 PNA-peptide conjugates selectively localize to bcl-2-positive tumors in mouse models of B-cell lymphoma.
Jia F; Balaji BS; Gallazzi F; Lewis MR
Nucl Med Biol; 2015 Nov; 42(11):809-15. PubMed ID: 26239085
[TBL] [Abstract] [Full Text] [Related]
17. RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1.
Prensner JR; Zhao S; Erho N; Schipper M; Iyer MK; Dhanasekaran SM; Magi-Galluzzi C; Mehra R; Sahu A; Siddiqui J; Davicioni E; Den RB; Dicker AP; Karnes RJ; Wei JT; Klein EA; Jenkins RB; Chinnaiyan AM; Feng FY
Lancet Oncol; 2014 Dec; 15(13):1469-1480. PubMed ID: 25456366
[TBL] [Abstract] [Full Text] [Related]
18. Everolimus and temsirolimus are not the same second-line in metastatic renal cell carcinoma. A systematic review and meta-analysis of literature data.
Iacovelli R; Santoni M; Verzoni E; Grassi P; Testa I; de Braud F; Cascinu S; Procopio G
Clin Genitourin Cancer; 2015 Apr; 13(2):137-41. PubMed ID: 25160521
[TBL] [Abstract] [Full Text] [Related]
19. Incidence of second malignancies for prostate cancer.
Van Hemelrijck M; Feller A; Garmo H; Valeri F; Korol D; Dehler S; Rohrmann S
PLoS One; 2014; 9(7):e102596. PubMed ID: 25047238
[TBL] [Abstract] [Full Text] [Related]
20. Diabetes mellitus without metformin intake is associated with worse oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
Rieken M; Xylinas E; Kluth L; Trinh QD; Lee RK; Fajkovic H; Novara G; Margulis V; Lotan Y; Martinez-Salamanca JI; Matsumoto K; Seitz C; Remzi M; Karakiewicz PI; Scherr DS; Briganti A; Kautzky-Willer A; Bachmann A; Shariat SF;
Eur J Surg Oncol; 2014 Jan; 40(1):113-20. PubMed ID: 24113620
[TBL] [Abstract] [Full Text] [Related]
[Next]
